Bidder, Not Bid, for Capitol Health Surprises Wilsons -- Market Talk
Capitol Health Enters Merger Deed With Integral Diagnostics; Shares Hit New 52-Week High
Integral Diagnostics Offer Values Capitol Health at Around A$347.5 Million
Capitol Health Says Integral Diagnostics Made Unsolicited Approach in Late March
Integral Diagnostics Offering 0.12849 Own Shares for Every Capitol Health Share
2 ASX Healthcare Shares to Buy Now for the AI Revolution
Integral Diagnostics Price Target Raised 3.8% to A$2.70/Share by Ord Minnett
Investors in Integral Diagnostics (ASX:IDX) Have Unfortunately Lost 40% Over the Last Three Years
How AI Could Boost This ASX 300 Healthcare Stock
While Institutions Own 40% of Integral Diagnostics Limited (ASX:IDX), Retail Investors Are Its Largest Shareholders With 44% Ownership
Capital Allocation Trends At Integral Diagnostics (ASX:IDX) Aren't Ideal
Morgan Stanley Adjusts Integral Diagnostics' Price Target to AU$1.85 From AU$1.70, Keeps at Underweight
Integral Diagnostics Price Target Raised 13% to A$2.20/Share by Citi
Integral Diagnostics Target Price Raised 8% to A$2.65/Share by Macquarie>IDX.AU
Integral Diagnostics Price Target Raised 4% to A$2.60/Share by Ord Minnett
Integral Diagnostics Posts 7% Rise in H1 FY24 Revenue, Profit Slips
Integral Diagnostics Revenue Up 12% in 2H So Far
Integral Diagnostics Expects FY 2024 Replacement, Growth Capex of A$30 Million-A$40 Million
Integral Diagnostics Expects 2H Operating Ebitda Margin in Line or Slightly Better Than 1H
Integral Diagnostics 1H Net Loss A$66.8 Million
No Data